当前位置:首页 - 行情中心 - 新光药业(300519) - 财务分析 - 现金流量表

新光药业

(300519)

  

流通市值:16.42亿  总市值:23.02亿
流通股本:1.14亿   总股本:1.60亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金208,264,730.49142,554,277.3294,519,204.9270,171,742.76
  收到其他与经营活动有关的现金1,830,052.281,588,283.461,077,327.3612,659,931.31
  经营活动现金流入小计210,094,782.77144,142,560.7895,596,532.26282,831,674.07
  购买商品、接受劳务支付的现金62,836,529.2735,571,500.3614,122,978.39122,907,289.1
  支付给职工以及为职工支付的现金25,615,579.1617,768,212.6410,316,078.7735,584,418.52
  支付的各项税费29,147,165.5721,846,307.4912,924,641.4433,592,144.4
  支付其他与经营活动有关的现金18,298,611.1111,178,251.726,429,139.4221,823,327.42
  经营活动现金流出小计135,897,885.1186,364,272.2143,792,838.02213,907,179.44
  经营活动产生的现金流量净额74,196,897.6657,778,288.5751,803,694.2468,924,494.63
二、投资活动产生的现金流量:
  收回投资收到的现金6,880,0006,880,0006,880,000-
  取得投资收益收到的现金4,440,845.583,739,905.031,059,551.055,941,645.95
  处置固定资产、无形资产和其他长期资产收回的现金净额112,6001,600-29,500
  收到的其他与投资活动有关的现金490,000,000430,000,000140,000,000635,000,000
  投资活动现金流入小计501,433,445.58440,621,505.03147,939,551.05640,971,145.95
  购建固定资产、无形资产和其他长期资产支付的现金399,976.75211,346.7553,746.753,475,750.9
  支付其他与投资活动有关的现金460,000,000430,000,00090,000,000850,000,000
  投资活动现金流出小计460,399,976.75430,211,346.7590,053,746.75853,475,750.9
  投资活动产生的现金流量净额41,033,468.8310,410,158.2857,885,804.3-212,504,604.95
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金1,000,0001,000,000-1,000,000
  筹资活动现金流入平衡项目00-0
  筹资活动现金流入小计1,000,0001,000,000-1,000,000
  分配股利、利润或偿付利息支付的现金48,000,00048,000,000-48,000,000
  支付其他与筹资活动有关的现金1,000,0001,000,000-1,000,000
  筹资活动现金流出平衡项目00-0
  筹资活动现金流出小计49,000,00049,000,000-49,000,000
  筹资活动产生的现金流量净额平衡项目00-0
  筹资活动产生的现金流量净额-48,000,000-48,000,000--48,000,000
五、现金及现金等价物净增加额67,230,366.4920,188,446.85109,689,498.54-191,580,110.32
  加:期初现金及现金等价物余额311,836,015.14311,836,015.14311,836,015.14503,416,125.46
  期末现金及现金等价物余额379,066,381.63332,024,461.99421,525,513.68311,836,015.14
补充资料:
  净利润-39,712,072.46-54,211,458.52
  资产减值准备--236,649.38-435,419.57
  固定资产和投资性房地产折旧-6,745,580.55-14,445,503.35
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-6,745,580.55-14,445,503.35
  无形资产摊销-145,311.58-290,623.16
  处置固定资产、无形资产和其他长期资产的损失---3,722.27
  固定资产报废损失--1,415.93-42,236.22
  投资损失--3,539,533.05--5,630,250.11
  递延所得税-103,183.58-211,038.78
  其中:递延所得税资产减少-103,183.58-211,038.78
  存货的减少-14,488,849.93-25,633,500.64
  经营性应收项目的减少--320,093.22-4,926,744.05
  经营性应付项目的增加-655,756.11--25,442,627.08
  现金的期末余额-332,024,461.99-311,836,015.14
  减:现金的期初余额-311,836,015.14-503,416,125.46
  现金及现金等价物的净增加额-20,188,446.85--191,580,110.32
公告日期2026-10-232026-08-252026-04-212026-04-21
审计意见(境内)标准无保留意见
TOP↑